Rachel A. Rabin
Cited by
Cited by
The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis
RA Rabin, KK Zakzanis, TP George
Schizophrenia research 128 (1-3), 111-116, 2011
A review of co‐morbid tobacco and cannabis use disorders: Possible mechanisms to explain high rates of co‐use
RA Rabin, TP George
The American journal on addictions 24 (2), 105-116, 2015
Effects of cigarette smoking status on delay discounting in schizophrenia and healthy controls
VC Wing, TG Moss, RA Rabin, TP George
Addictive Behaviors 37 (1), 67-72, 2012
Neurocognitive endophenotypes in schizophrenia: modulation by nicotinic receptor systems
KM Mackowick, MS Barr, VC Wing, RA Rabin, C Ouellet-Plamondon, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 52, 79-85, 2014
Effects of cannabis use status on cognitive function, in males with schizophrenia
RA Rabin, KK Zakzanis, ZJ Daskalakis, TP George
Psychiatry research 206 (2-3), 158-165, 2013
Co‐morbid tobacco use disorder and depression: A re‐evaluation of smoking cessation therapy in depressed smokers
M Morozova, RA Rabin, TP George
The American Journal on Addictions 24 (8), 687-694, 2015
Correlation of Prepulse Inhibition and Wisconsin Card Sorting Test in Schizophrenia and Controls: Effects of smoking status
RA Rabin, KA Sacco, TP George
Schizophrenia research 114 (1-3), 91-97, 2009
Effects of extended cannabis abstinence on cognitive outcomes in cannabis dependent patients with schizophrenia vs non-psychiatric controls
RA Rabin, MS Barr, MS Goodman, Y Herman, KK Zakzanis, SJ Kish, ...
Neuropsychopharmacology 42 (11), 2259-2271, 2017
Varenicline modulates spatial working memory deficits in smokers with schizophrenia.
VC Wing, CE Wass, I Bacher, RA Rabin, TP George
Elsevier Science, 2013
Does cannabis use moderate smoking cessation outcomes in treatment‐seeking tobacco smokers? Analysis from a large multi‐center trial
RA Rabin, RL Ashare, RA Schnoll, PM Cinciripini, LW Hawk Jr, C Lerman, ...
The American journal on addictions 25 (4), 291-296, 2016
Understanding the link between cannabinoids and psychosis
RA Rabin, TP George
Clinical Pharmacology & Therapeutics 101 (2), 197-199, 2017
Effects of extended cannabis abstinence on clinical symptoms in cannabis dependent schizophrenia patients versus non-psychiatric controls
RA Rabin, K Kozak, KK Zakzanis, G Remington, TP George
Schizophrenia research 194, 55-61, 2018
A method to achieve extended cannabis abstinence in cannabis dependent patients with schizophrenia and non-psychiatric controls
RA Rabin, K Kozak, KK Zakzanis, G Remington, C Stefan, AJ Budney, ...
Schizophrenia research 194, 47-54, 2018
Relationship between tobacco and cannabis use status in outpatients with schizophrenia
RA Rabin, JL Giddens, TP George
The American Journal on Addictions 23 (2), 170-175, 2014
Correlations between executive function, decision-making and impulsivity are disrupted in schizophrenia versus controls
VC Wing, RA Rabin, CE Wass, TP George
Psychiatry research 205 (1-2), 168-171, 2013
Nicotinic receptor mechanisms in neuropsychiatric disorders: therapeutic implications
I Bacher, RA Rabin, AA Woznica, S KA, G TP
Primary Psychiatry 17 (1), 35-41, 2010
Treatment implications associated with cannabis and tobacco Co-Use
EA McClure, RA Rabin, DC Lee, C Hindocha
Current Addiction Reports 7 (4), 533-544, 2020
The Cannabis-Psychosis Link
MJ Lynch, RA Rabin, TP George
Psychiatric Times 29 (6), 35-35, 2012
Common and gender-specific associations with cocaine use on gray matter volume: Data from the ENIGMA addiction working group
RA Rabin, S Mackey, MA Parvaz, J Cousijn, CS Li, G Pearlson, ...
Human brain mapping, 2020
Differential effects of cannabis dependence on cortical inhibition in patients with schizophrenia and non-psychiatric controls
MS Goodman, AC Bridgman, RA Rabin, DM Blumberger, TK Rajji, ...
Brain stimulation 10 (2), 275-282, 2017
The system can't perform the operation now. Try again later.
Articles 1–20